A Study Using US Medical and Pharmacy Claim Records to Compare the Resource Use, Cost, and Outcomes of People With COPD Who Take Either Tiotropium + Olodaterol or Fluticasone + Umeclidinium + Vilanterol
Clinical trial NCT05127304 · COMPLETED
Trial details
- NCT number
- NCT05127304
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-02-26
- Primary completion
- 2022-02-03
- Enrollment
- 11316
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.